"New hope" for patients with blood cancers not responding to treatment
Peter Mac’s Associate Professor Michael Dickinson has presented new data from a trial of the investigational blood cancer drug Glofitamab, at the annual meeting of the American Society of Clinical Oncology (ASCO)... Read more